TDE-HF-302 Open-label extension study of oral Treprostinil in subjects with Pulmonary Hypertension associated wiht Heart Failure with Preserved Ejection Fraction- A long-term follow-up to TDE-HF-301

Administered By

Awarded By

Contributors

Start/End

  • November 7, 2017 - September 30, 2022